Skip to main content
. Author manuscript; available in PMC: 2008 Apr 1.
Published in final edited form as: J Pain Symptom Manage. 2007 Apr;33(4):398–409. doi: 10.1016/j.jpainsymman.2006.09.022

Table 3.

Actigraph for Sleep/Wake, Activity/Rest, and Circadian Rhythms Prior to Chemotherapy (n=128–130)

Variable Mean SD Range
Sleep/wake
Sleep-onset latency (min) 11.38 17.88 0–187
Wake after sleep onset (WASO) (min/hr) 62.49/1.04 66.01 0–427 min
Number of awakenings 9.70 5.47 0–27.5
Total sleep time (min/hr) 396.84/6.61 95.74 90.0–604.5
Sleep efficiency (percentage) 86.13 15.14 17.4–100
Percent Wake night 13.87 15.14 0–82.6
Activity/rest
Mean daytime activity 188.37 35.89 57.1–250.1
Total sleep time (min/hr) 64.17/1.07 57.79 0–285
Total wake time (min/hr) 829.72/13.83 133.53 71.5–1081
Sleep percent day 7.49 7.57 0–52.1
Wake percent day 92.51 7.57 47.9–100
Circadian rhythms
Mesor 132.25 24.56 52.2–187
Amplitude 97.18 22.80 26.4–145.7
Acrophase 12:59 - -
Goodness of Fit 0.62 0.11 0.3–0.88

SD = standard deviation.